Literature DB >> 21517188

Validating the factor structure of the Self-Report Psychopathy scale in a community sample.

Mehmet K Mahmut1, Con Menictas, Richard J Stevenson, Judi Homewood.   

Abstract

Currently, there is no standard self-report measure of psychopathy in community-dwelling samples that parallels the most commonly used measure of psychopathy in forensic and clinical samples, the Psychopathy Checklist. A promising instrument is the Self-Report Psychopathy scale (SRP), which was derived from the original version the Psychopathy Checklist. The most recent version of the SRP (SRP-III; D. L. Paulhus, C. S. Neumann, & R. D. Hare, in press) has shown good convergent and discriminate validity and a factor structure similar to the current version of the Psychopathy Checklist (PCL-R; R. D. Hare, 1991, 2003). The analyses in the current study further investigated the viability of the SRP-III as a PCL-R-analogous measure of psychopathy in nonforensic and nonclinical samples by extending the validation process to a community sample. Using confirmatory factor analyses and logistic regressions, the results revealed that a four-factor oblique model for the SRP-III was most tenable, congruent with the PCL-R factor structure of psychopathy and previous research in which the SRP-III was administered to a student sample.

Entities:  

Mesh:

Year:  2011        PMID: 21517188     DOI: 10.1037/a0023090

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  20 in total

1.  Factor structure of the Hare Psychopathy Checklist: Youth Version (PCL:YV) in adolescent females.

Authors:  David S Kosson; Craig S Neumann; Adelle E Forth; Randall T Salekin; Robert D Hare; Maya K Krischer; Kathrin Sevecke
Journal:  Psychol Assess       Date:  2012-06-25

2.  The neural signatures of distinct psychopathic traits.

Authors:  Justin M Carré; Luke W Hyde; Craig S Neumann; Essi Viding; Ahmad R Hariri
Journal:  Soc Neurosci       Date:  2012-07-09       Impact factor: 2.083

3.  Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder.

Authors:  Joseph L Alcorn; Joshua L Gowin; Charles E Green; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2013       Impact factor: 2.198

4.  Examining the Factor Structure of the Self-Report of Psychopathy Short-Form Across Four Young Adult Samples.

Authors:  Hailey L Dotterer; Rebecca Waller; Craig S Neumann; Daniel S Shaw; Erika E Forbes; Ahmad R Hariri; Luke W Hyde
Journal:  Assessment       Date:  2016-04-06

5.  Psychopathic individuals exhibit but do not avoid regret during counterfactual decision making.

Authors:  Arielle Baskin-Sommers; Allison M Stuppy-Sullivan; Joshua W Buckholtz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

6.  A Validation of the Inventory of Callous-Unemotional Traits in a Community Sample of Young Adult Males.

Authors:  Amy L Byrd; Rachel E Kahn; Dustin A Pardini
Journal:  J Psychopathol Behav Assess       Date:  2013-03-01

7.  Testing helping behavior and its relationship to antisocial personality and psychopathic traits.

Authors:  Joseph T Sakai; Kristen M Raymond; Shannon K McWilliams; Susan K Mikulich-Gilbertson
Journal:  Psychiatry Res       Date:  2019-02-11       Impact factor: 3.222

8.  Primary and Secondary Variants of Psychopathy in a Volunteer Sample Are Associated With Different Neurocognitive Mechanisms.

Authors:  Arjun Sethi; Eamon McCrory; Vanessa Puetz; Ferdinand Hoffmann; Annchen R Knodt; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri; Essi Viding
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-04-12

9.  Effects of Intranasal Oxytocin on Aggressive Responding in Antisocial Personality Disorder.

Authors:  Joseph L Alcorn; Nuvan Rathnayaka; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  Psychol Rec       Date:  2015-09-09

10.  Effects of oxytocin on aggressive responding in healthy adult men.

Authors:  Joseph L Alcorn; Charles E Green; Joy Schmitz; Scott D Lane
Journal:  Behav Pharmacol       Date:  2015-12       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.